Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $14.90 billion. The enterprise value is $17.44 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 62.74 million shares outstanding. The number of shares has decreased by -5.13% in one year.
| Current Share Class | 62.74M |
| Shares Outstanding | 62.74M |
| Shares Change (YoY) | -5.13% |
| Shares Change (QoQ) | +4.20% |
| Owned by Insiders (%) | 3.01% |
| Owned by Institutions (%) | 103.19% |
| Float | 60.80M |
Valuation Ratios
The trailing PE ratio is 505.85 and the forward PE ratio is 9.74. JAZZ's PEG ratio is 0.18.
| PE Ratio | 505.85 |
| Forward PE | 9.74 |
| PS Ratio | 3.36 |
| Forward PS | 3.25 |
| PB Ratio | 3.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.73 |
| P/OCF Ratio | 11.17 |
| PEG Ratio | 0.18 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 13.74.
| EV / Earnings | 592.18 |
| EV / Sales | 3.93 |
| EV / EBITDA | 8.68 |
| EV / EBIT | 13.46 |
| EV / FCF | 13.74 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 1.20.
| Current Ratio | 2.04 |
| Quick Ratio | 1.65 |
| Debt / Equity | 1.20 |
| Debt / EBITDA | 2.66 |
| Debt / FCF | 4.27 |
| Interest Coverage | 4.93 |
Financial Efficiency
Return on equity (ROE) is 0.68% and return on invested capital (ROIC) is 18.02%.
| Return on Equity (ROE) | 0.68% |
| Return on Assets (ROA) | 6.92% |
| Return on Invested Capital (ROIC) | 18.02% |
| Return on Capital Employed (ROCE) | 13.48% |
| Weighted Average Cost of Capital (WACC) | 5.24% |
| Revenue Per Employee | $1.54M |
| Profits Per Employee | $10,191 |
| Employee Count | 2,890 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.81 |
Taxes
| Income Tax | -248.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +117.88% in the last 52 weeks. The beta is 0.27, so JAZZ's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +117.88% |
| 50-Day Moving Average | 199.98 |
| 200-Day Moving Average | 163.00 |
| Relative Strength Index (RSI) | 74.65 |
| Average Volume (20 Days) | 968,094 |
Short Selling Information
The latest short interest is 5.09 million, so 8.11% of the outstanding shares have been sold short.
| Short Interest | 5.09M |
| Short Previous Month | 5.24M |
| Short % of Shares Out | 8.11% |
| Short % of Float | 8.37% |
| Short Ratio (days to cover) | 5.60 |
Income Statement
In the last 12 months, JAZZ had revenue of $4.44 billion and earned $29.45 million in profits. Earnings per share was $0.47.
| Revenue | 4.44B |
| Gross Profit | 4.06B |
| Operating Income | 1.30B |
| Pretax Income | -219.09M |
| Net Income | 29.45M |
| EBITDA | 2.01B |
| EBIT | 1.30B |
| Earnings Per Share (EPS) | $0.47 |
Full Income StatementBalance Sheet
The company has $2.87 billion in cash and $5.42 billion in debt, with a net cash position of -$2.54 billion or -$40.52 per share.
| Cash & Cash Equivalents | 2.87B |
| Total Debt | 5.42B |
| Net Cash | -2.54B |
| Net Cash Per Share | -$40.52 |
| Equity (Book Value) | 4.53B |
| Book Value Per Share | 72.29 |
| Working Capital | 2.34B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.33 billion and capital expenditures -$64.55 million, giving a free cash flow of $1.27 billion.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -64.55M |
| Depreciation & Amortization | 712.90M |
| Net Borrowing | -31.00M |
| Free Cash Flow | 1.27B |
| FCF Per Share | $20.24 |
Full Cash Flow StatementMargins
Gross margin is 91.50%, with operating and profit margins of 29.18% and 0.66%.
| Gross Margin | 91.50% |
| Operating Margin | 29.18% |
| Pretax Margin | -4.94% |
| Profit Margin | 0.66% |
| EBITDA Margin | 45.24% |
| EBIT Margin | 29.18% |
| FCF Margin | 28.60% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.13% |
| Shareholder Yield | 5.13% |
| Earnings Yield | 0.20% |
| FCF Yield | 8.52% |
Dividend DetailsAnalyst Forecast
The average price target for JAZZ is $248.76, which is 4.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $248.76 |
| Price Target Difference | 4.76% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 5.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.77 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 6 |
